Determinants of lower extremity amputation or revascularization procedure in patients with peripheral artery diseases: A population-based investigation

Angiology

Volumn 62, Issue 4, 2011, Pages 306-309

  Chen, Jien Jiun ^a   Lee, Chang Hsing ^b,c   Lin, Lian Yu ^a   Liau, Chiau Suong ^d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c Ton Yen General Hospital   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

amputation; diabetes mellitus; peripheral artery disease

Indexed keywords

CILOSTAZOL;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; GROUPS BY AGE; HUMAN; HYPERTENSION; LEG AMPUTATION; LEG REVASCULARIZATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPULATION RESEARCH; RISK FACTOR; TAIWAN;

AGED; AMPUTATION; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; LOWER EXTREMITY; MALE; PERIPHERAL ARTERIAL DISEASE; RISK FACTORS; TAIWAN; TETRAZOLES; VASODILATOR AGENTS;

EID: 79953873851     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319710382771     Document Type: Article

References (29)

1. Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med. 1986 ; 314 (8). 488-500.
2. Hiatt WR Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001 ; 344 (21). 1608-1621. (Pubitemid 32479915)
3. Fowkes FG, Housley E., Riemersma RA, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol. 1992 ; 135 (4). 331-340.
4. Pell JP, Donnan PT, Fowkes FG, Ruckley CV Quality of life following lower limb amputation for peripheral arterial disease. Eur J Vasc Surg. 1993 ; 7 (4). 448-451. (Pubitemid 23223771)
5. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003 ; 26 (12). 3333-3341.
6. Kudo T., Chandra FA, Ahn SS The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience. J Vasc Surg. 2005 ; 41 (3). 423-435 ; discussion 435. (Pubitemid 40523584)
7. Marso SP, Hiatt WR Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 2006 ; 47 (5). 921-929.
8. Hankey GJ, Norman PE, Eikelboom JW Medical treatment of peripheral arterial disease. JAMA. 2006 ; 295 (5). 547-553. (Pubitemid 43200349)
9. Jude EB, Oyibo SO, Chalmers N., Boulton AJ Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001 ; 24 (8). 1433-1437. (Pubitemid 33716433)
10. Calle-Pascual AL, Redondo MJ, Ballesteros M., et al. Nontraumatic lower extremity amputations in diabetic and non-diabetic subjects in Madrid, Spain. Diabetes Metab. 1997 ; 23 (6). 519-523. (Pubitemid 28057255)
11. Trautner C., Haastert B., Giani G., Berger M. Amputations and diabetes: a case-control study. Diabet Med. 2002 ; 19 (1). 35-40. (Pubitemid 34146635)
12. Lu JF, Hsiao WC Does universal health insurance make health care unaffordable? Lessons from Taiwan. Health Aff (Millwood). 2003 ; 22 (3). 77-88. (Pubitemid 41388746)
13. Chiang TL Taiwan's 1995 health care reform. Health Policy. 1997 ; 39 (3). 225-239.
14. Tseng CH Mortality and causes of death in a national sample of diabetic patients in Taiwan. Diabetes Care. 2004 ; 27 (7). 1605-1609.
15. Chen HF, Ho CA, Li CY Age and sex may significantly interact with diabetes on the risks of lower-extremity amputation and peripheral revascularization procedures: evidence from a cohort of a half-million diabetic patients. Diabetes Care. 2006 ; 29 (11). 2409-2414.
16. Garcia LA Epidemiology and pathophysiology of lower extremity peripheral arterial disease. J Endovasc Ther. 2006 ; 13 (suppl2): 113-119.
17. Guzman RJ, Brinkley DM, Schumacher PM, Donahue RM, Beavers H., Qin X. Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease. J Am Coll Cardiol. 2008 ; 51 (20). 1967-1974. (Pubitemid 351636450)
18. Lee TT, Cheng SH, Chen CC, Lai MS A pay-for-performance program for diabetes care in Taiwan: a preliminary assessment. Am J Manag Care. 2010; 16 (1). 65-69.
19. Holstein P., Ellitsgaard N., Olsen BB, Ellitsgaard V. Decreasing incidence of major amputations in people with diabetes. Diabetologia. 2000 ; 43 (7). 844-847. (Pubitemid 30463162)
20. van Houtum WH, Rauwerda JA, Ruwaard D., Schaper NC, Bakker K. Reduction in diabetes-related lower-extremity amputations in The Netherlands: 1991-2000. Diabetes Care. 2004 ; 27 (5). 1042-1046. (Pubitemid 38579763)
21. Kohda N., Tani T., Nakayama S., et al. Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery. Thromb Res. 1999 ; 96 (4). 261-268.
22. Creager MA Medical management of peripheral arterial disease. Cardiol Rev. 2001 ; 9 (4). 238-245.
23. Igawa T., Tani T., Chijiwa T., et al. Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells. Thromb Res. 1990 ; 57 (4). 617-623. (Pubitemid 20110427)
24. Robless P., Mikhailidis DP, Stansby GP Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev. 2008 (1). CD003748.
25. Regensteiner JG, Ware JE Jr, McCarthy WJ, et al. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J Am Geriatr Soc. 2002 ; 50 (12). 1939-1946. (Pubitemid 35462438)
26. Tsuchikane E., Fukuhara A., Kobayashi T., et al. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty. Circulation. 1999 ; 100 (1). 21-26. (Pubitemid 29297935)
27. Douglas JS Jr, Holmes DR Jr, Kereiakes DJ, et al. Coronary stent restenosis in patients treated with cilostazol. Circulation. 2005 ; 112 (18). 2826-2832. (Pubitemid 41641677)
28. Iida O., Nanto S., Uematsu M., et al. Cilostazol reduces target lesion revascularization after percutaneous transluminal angioplasty in the femoropopliteal artery. Circ J. 2005 ; 69 (10). 1256-1259. (Pubitemid 41382949)
29. Assaf AR, Lapane KL, McKenney JL, Carleton RA Possible influence of the prospective payment system on the assignment of discharge diagnoses for coronary heart disease. N Engl J Med. 1993 ; 329 (13). 931-935. (Pubitemid 23275276)